FDA warns Longford Water Company that its bottled drinking water was made under insanitary conditions and without required treatment validation and testing.
What happened
FDA inspected the Longford, KS bottled water facility on March 17-18, 2025. FDA found the company could not show its water treatment was effective, did not test each type of bottled water weekly for bacteria, did not test containers and closures quarterly, and did not clean and sanitize all product-water contact surfaces with complete records. FDA said these violations make the bottled water adulterated, meaning it may be unsafe because of insanitary conditions.
What FDA found
The company could not show that its redacted water treatment process was effective, keep records of its concentration and duration, or show the residual level at bottling was within the required limit.
21 CFR 129.80(a); 21 CFR 184.1563The company did not test a representative sample from each type of bottled drinking water at least once a week for bacteria, and it did not dechlorinate samples as the test directions say.
21 CFR 129.80(g)(1)The company did not sample and inspect containers and closures at least quarterly, including bacteriological swab or rinse counts from at least four containers and closures before filling.
21 CFR 129.80(f)The company did not clean and adequately sanitize all product-water-contact surfaces and did not keep complete records of these operations.
21 CFR 129.37(a)
What FDA wants
FDA asks the company to reply in writing within 15 working days with the specific corrections taken, steps to prevent recurrence, and supporting documents. If corrections cannot be completed in that time, the company must state why and give a completion date.
Who should pay attention
- bottled water brands and co-packers using this facility
- distributors and retailers selling Longford Water products
- quality teams at small bottled water plants
This is a summary. Read the original letter on fda.gov.